Search - tctmd.com

Displaying 201 - 220 of 322

Sort: Relevancy | Date

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Conference News HRS 2018

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

Todd Neale

May 11, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Michael O'Riordan

April 17, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

Presentation ACC 2018

The PHARMCLO Study: A Prospective, Randomised, Multicentre Study of a Pharmacogenomic Approach to the Selection of Antiplatelet Therapy in Acute Coronary Syndromes

Presenter: Diego Ardissino

March 12, 2018

Presentation ACC 2018

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

Presenter: Francesco Franchi

March 11, 2018

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Shelley Wood

March 11, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Prolonged DAPT Does Not Increase Mortality, Cancer Risk: More Evidence

L.A. McKeown

January 12, 2018

News Daily News

Shifts in Stroke Score Over Time Help Hone Risk Prediction

Todd Neale

January 10, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

Advertisement

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

The PHARMCLO Study: A Prospective, Randomised, Multicentre Study of a Pharmacogenomic Approach to the Selection of Antiplatelet Therapy in Acute Coronary Syndromes

Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Ticagrelor: Better Platelet Blockade Post-TAVR?

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

TCTMD’s Top 10 Most Popular Stories for January 2018

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Prolonged DAPT Does Not Increase Mortality, Cancer Risk: More Evidence

Shifts in Stroke Score Over Time Help Hone Risk Prediction

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content